To dissect the functional relevance of CDK5 expression and activity in modulating DLBCL malignant phenotypes, we studied the effects of CDK5 and p35 loss- and gain-of-function on proliferation in different DLBCL cell lines. This evidence concerns the gene CDK5 and diffuse large B-cell lymphoma.